1,876 results on '"Kvien, Tore K"'
Search Results
202. Nonsteroidal Anti-Inflammatory Drugs and Coxibs
203. Contributors
204. Severity of musculoskeletal pain: relations to socioeconomic inequality
205. Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry
206. Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
207. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria
208. Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index
209. Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study
210. Associations between MRI-defined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis
211. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort
212. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
213. Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naïve patients with early RA
214. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts
215. Novel genetic association of the VTCN1 region with rheumatoid arthritis
216. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
217. Comparison of features by MRI and radiographs of the interphalangeal finger joints in patients with hand osteoarthritis
218. OPINION: What is the clinical relevance of erosions and joint space narrowing in RA?
219. Efficacy of different doses of rituximab for the treatment of RA: data From the CERERRA collaboration
220. Contributors
221. Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register
222. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
223. Tenosynovitis of the extensor carpi ulnaris tendon predicts erosive progression in early rheumatoid arthritis
224. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
225. Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study
226. Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis
227. Fertility in women with chronic inflammatory arthritides
228. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth
229. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis
230. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score
231. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
232. Sleep problems are of higher priority for improvement for patients with ankylosing spondylitis than for patients with other inflammatory arthropathies
233. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
234. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis
235. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
236. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
237. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression
238. Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
239. Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients
240. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
241. 104 - Multidisciplinary nonpharmacologic approach to rheumatoid arthritis
242. Associations Between Ultrasound‐Detected Synovitis, Pain, and Function in Interphalangeal and Thumb Base Osteoarthritis: Data From the Nor‐Hand Cohort
243. What Next after Biologic Therapy Fails in Rheumatoid Arthritis?
244. Response to: ‘Correspondence on ‘Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study’’ by Hunget al
245. Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration
246. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
247. Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study
248. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
249. Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register
250. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.